Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers discover 'promising' new treatment for canine epilepsy
Adding MCT oil to a dried-kibble diet may reduce epileptic seizures and improve a dog's quality of life.
Study highlights the potential of MCT oil for reducing seizures and improving quality of life.

Researchers at the Royal Veterinary College (RVC) have discovered a promising new treatment for hard-to-treat canine epilepsy.

Scientists tested the effects of an oil supplement on seizure frequency in dogs with drug-resistant epilepsy. They found that adding the oil to a dog's existing diet reduced seizures and improved quality of life for both dog and owner.

The research was funded by The American Kennel Club Canine Health Foundation and is published in the Journal of Veterinary Internal Medicine.

Dr Rowena Packer, BBSRC Research Fellow at the RVC said: “Our novel findings indicate that a relatively small change to the diet of dogs’ with hard-to-treat epilepsy can potentially reduce the number of seizures they have, while also improving their medication side effects and overall quality of life.”

The study built on previous research that found the oil contained a specific type of fat (medium-chain triglycerides (MCT)) that could have beneficial effects when added to a dried-kibble diet.

The oil was tested during a rigorous trial, in which 28 dogs received the MCT oil for three months and a placebo oil for three months. Neither the researchers or the dogs' owners knew which oil the dogs were receiving at any given time.

Overall, they observed that dogs had significantly fewer seizures during the MCT phase compared to the placebo phase, and improved owner-reported quality of life.

Dr Packer adds: “Epilepsy is often a challenging and distressing condition for dog owners to manage, particularly when dogs don’t respond to anti-seizure medications in the way their owner and vet might have expected or hoped.

“Historically, diet has not been considered a key part of epilepsy management, but along with other recent findings, these results indicate that nutrition likely plays an important role in seizure control.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.